Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Current Issue

September 2025

A Place for Patient Organizations

Patient organizations connect physicians with a community that benefits from their expertise, and they offer patients the education and support they need to navigate a hematologic diagnosis.


 

Viewpoints

Editor’s Corner

What’s Your Ki67?

Letter to the Editor

Bearing Witness: The Silent Weight of Moral Injury in Oncology

Guest Commentary

Bridging the Gap: How Hematology Can Better Support Patient Wellness

Education

You Make the Call

You Make the Call: How would you proceed to diagnosis in a patient with macrocytic anemia, Coombs-negative hemolysis, and PE?

You Make the Call: Reader's Response

How would you proceed to diagnosis in a patient with macrocytic anemia, Coombs-negative hemolysis, and PE?

Practice Update

Keeping Up With GLP-1s: What Hematologists Need to Know

Spotlight

Feature Articles

A Place for Patient Organizations

Blood Beyond Borders

Pakistan Continues Progress in Establishing, Expanding Hematology Practices

News

In a Different Vein: News from the Blood Journals

Study Identifies CD38 Mutations That Confer Resistance to CD38-Targeting Antibodies in Patients with Multiple Myeloma
Marstacimab Provides New Prophylactic Option for Hemophilia A, B
Single-Run NGS Approach for MDS Improves Diagnostic Accuracy, Workflow in Resource-Constrained Setting

Literature Scan

Phase IIIb Results Show Avatrombopag to Be Safe, Effective Treatment for Children With ITP
IMS-IMWG Releases New Consensus Definition of High-Risk MM Based on Genomics
Cyclosporin-Cyclophosphamide Performs Well for GVHD Prevention After Transplant
Individualized Therapy Associated With Greater Rates of Undetectable MRD, Extended PFS in CLL

ASH Directions

ASH Celebrates 10 Years of Deep Investment, Commitment to Sickle Cell Disease
ASH Names Next Editor-in-Chief of ASH Clinical News

Data Stream

September 2025 Data Stream

Online Only

Latest & Greatest

PDUFA Pending Update: Glofitamab-gxbm in R/R DLBCL
PDUFA Pending Update: Belantamab Mafodotin in R/R MM
LLS Changes Name
FDA Approves Linvoseltamab for R/R MM

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals